Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimer’s Disease

MLA

Sameer M. Joshi, et al. “Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimer’s Disease.” Molecules, vol. 29, no. 2, Jan. 2024, p. 488. EBSCOhost, https://doi.org/10.3390/molecules29020488.

APA

Sameer M. Joshi, Thomas C. Wilson, Zibo Li, Sean Preshlock, Vanessa Gómez-Vallejo, Véronique Gouverneur, Jordi Llop, & Gemma Arsequell. (2024). Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimer’s Disease. Molecules, 29(2), 488. https://doi.org/10.3390/molecules29020488

Chicago

Sameer M. Joshi, Thomas C. Wilson, Zibo Li, Sean Preshlock, Vanessa Gómez-Vallejo, Véronique Gouverneur, Jordi Llop, and Gemma Arsequell. 2024. “Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimer’s Disease.” Molecules 29 (2): 488. doi:10.3390/molecules29020488.